Here’s their press release

(New York, N.Y., December 8, 2020) — Viridian Capital Advisors is pleased to announce that Mr. Jon Decourcey has joined the firm as Director of Equity Research.
Mr. Decourcey joined the Canaccord Genuity equity research team in 2014, initially in the Infrastructure and Manufacturing Technology sector, and since 2018, with a focus on the Cannabis sector. There, he was responsible for the research coverage of public companies involved in the U.S. cannabis industry, from vertically integrated cannabis operators, to branded products manufacturers and ancillary service providers. He also developed and maintained proprietary market forecast models for the U.S. cannabis and hemp-derived CBD markets overall, and for specific states individually.
Before joining Canaccord Genuity, Mr. Decourcey worked at GW&K Investment Management, an asset management firm with $47 billion in assets under management, in the firm’s equity research and equity trading departments. Prior, he worked as an analyst for Brown Brothers Harriman.
Mr. Decourcey graduated from the Babson College with a B.S. degree in Business Management, and received his MBA from Boston College.

Scott Greiper, President and Founder of Viridian Capital, commented, “The opportunity to bring on an equity research analyst with the cannabis industry insight and investor following that Jon Decourcey has built is exciting for our firm. His research, along with our proprietary data-driven report, the Viridian Cannabis Deal Tracker, positions our firm as a thought leader and at the forefront of insight into the ever-changing capital markets in the cannabis industry. Adding research capabilities improves our value proposition to our key constituents, investors and corporate clients, and completes our evolution to becoming a full service investment bank serving the cannabis industry.”